LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Inicio・Lista de Acciones・Dynavax Technologies Corp

Dynavax Technologies Corp

Abierto

Sector Salud

11.08 -0.89

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

11.03

Máximo

11.23

Métricas clave
By Trading Economics
Ingresos	20M 11M
Ventas	23M 74M
P/B Media del Sector	160.43 103.001
BPA	0.08
Margen de beneficio	15.428
Empleados	408
EBITDA	26M 18M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+119.34 upside

Dividendos
By Dow Jones
Próximas Ganancias	31 oct 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	-26M 1.5B
Apertura anterior	11.97
Cierre anterior	11.08

Noticias sobre sentimiento de mercado

By Acuity

50%

97 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

10.88 / 11.32 Soporte y Resistencia

Dynavax Technologies Corp Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

14 sept 2024, 01:45 UTC

Ganancias

Preview -- Barron's

13 sept 2024, 20:03 UTC

Principales Noticias

Walgreens to Pay $106.8 Million Over Alleged Fraudulent Healthcare Billings

15 sept 2024, 23:47 UTC

Charlas de Mercado

Gold Edges Higher Amid Mild Dollar Weakness -- Market Talk

15 sept 2024, 23:03 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

15 sept 2024, 23:03 UTC

Charlas de Mercado

Australian Bond Traders Watchful as Fed Easing Nears -- Market Talk

15 sept 2024, 16:52 UTC

Principales Noticias

Boeing Machinist Strike Adds Cash Crunch to New CEO's Rescue Mission -- WSJ

15 sept 2024, 09:30 UTC

Principales Noticias

Interest Rates Are Too High. The Fed Should Cut by a Half Point. -- WSJ

15 sept 2024, 07:00 UTC

Principales Noticias

World's Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna -- Barrons.com

14 sept 2024, 14:09 UTC

Principales Noticias

Disney, DirecTV Reach Deal, Ending Blackout of ABC, ESPN -- Update 1 -- WSJ

14 sept 2024, 13:25 UTC

Principales Noticias

Disney, DirecTV Reach Deal, Ending Blackout of ABC, ESPN -- WSJ

14 sept 2024, 09:30 UTC

Principales Noticias

Why a Fed Rate Cut Won't Solve the Housing Wealth Gap -- WSJ

14 sept 2024, 09:30 UTC

Principales Noticias

Americans Are Falling Behind on Their Bills. Wall Street Is Alarmed. -- WSJ

14 sept 2024, 03:00 UTC

Principales Noticias

What Scared Ford's CEO in China -- WSJ

14 sept 2024, 03:00 UTC

Principales Noticias

What Scared Ford's CEO in China -- WSJ -2-

14 sept 2024, 00:01 UTC

Principales Noticias

Why 96% of Boeing's Machinists Voted to Go on Strike -- Update

13 sept 2024, 21:14 UTC

Principales Noticias

Why 96% of Boeing's Machinists Voted to Go on Strike -- WSJ

13 sept 2024, 21:06 UTC

Principales Noticias

Starliner Astronauts Say NASA Ran Short of Time to Test Boeing Craft -- WSJ

13 sept 2024, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

13 sept 2024, 20:47 UTC

Charlas de Mercado

Saudi Arabia Credit Outlook Raised to Positive on Economic Investments -- Market Talk

13 sept 2024, 20:44 UTC

Adquisiciones, fusiones, absorciones

Schlumberger Stock Was Once as Hot as Nvidia. Why It's a Buy. -- Barrons.com

13 sept 2024, 20:41 UTC

Principales Noticias

Berkshire Hathaway's Stock Is So Rich Even Berkshire Is Buying Less of It -- Update

13 sept 2024, 20:31 UTC

Ganancias

These Stocks Moved the Most Today: Adobe, Boeing, Trump Media, Oracle, Uber, RH, Moderna, Etsy, and More -- Barrons.com

13 sept 2024, 20:13 UTC

Adquisiciones, fusiones, absorciones

BlackRock: Expects to Close Previously Announced Acquisition of Global Infrastructure Partners on Oct 1 >BLK

13 sept 2024, 20:10 UTC

Adquisiciones, fusiones, absorciones

BlackRock Announces Expected Closing Date For Acquisition Of Global Infrastructure Partners >BLK

13 sept 2024, 20:02 UTC

Adquisiciones, fusiones, absorciones

CGI Completes Acquisition Of Aeyon, Expands Capabilities For National Security And Civilian Agency Missions >GIB

13 sept 2024, 20:02 UTC

Adquisiciones, fusiones, absorciones

CGI Completes Acquisition Of Aeyon, Expands Capabilities For National Security And Civilian Agency Missions >GIB

13 sept 2024, 19:44 UTC

Charlas de Mercado

Treasury Yields Fall as Odds of 50bp Fed Cut Rise -- Market Talk

13 sept 2024, 19:20 UTC

Charlas de Mercado

Crude-Oil Futures End Week With Small Gains -- Market Talk

13 sept 2024, 19:09 UTC

Charlas de Mercado

U.S. Natural-Gas Futures Post Weekly Gain -- Market Talk

13 sept 2024, 18:01 UTC

Charlas de Mercado

Gold Analysts Call For New Leg Of Rally -- Market Talk

Comparación entre iguales

Cambio de precio

Dynavax Technologies Corp Esperado

Precio Objetivo

By TipRanks

119.34% repunte

Estimación a 12 meses

Media 24.5 USD 119.34%

Máximo 29 USD

Mínimo 15 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Dynavax Technologies Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Dynavax Technologies Corp Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

10.88 / 11.32Soporte y Resistencia

The bullish and bearish events are balanced.

Recent bearish events outweigh bullish events.

There are no events.

Sentimiento

By Acuity

97 / 365 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Dynavax Technologies Corp

Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company that is focused on developing and commercializing novel vaccines. The Company's products include HEPLISAV-B and CpG 1018TM. The HEPLISAV-B is for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The Company also manufactures and sells CpG 1018TM, the adjuvant used in HEPLISAV-B. The Company also engaged in developing CpG 1018 as a premier vaccine adjuvant through research collaborations and partnerships.